Ticker

Disc Medicine (IRON) is experiencing a significant surge today following the announcement of positive results from its pivotal Phase 3 APOLLO trial for bitopert

Positive APOLLO trial topline results demonstrated statistically significant and clinically meaningful benefit across all study endpoints Successfully met co-primary endpoints of reduction in protoporphyrin IX (PPIX) and increased total time in light All secondary endpoint results were also positive and statistically significant, including reductions in phototoxic reactions and improvements on multiple measures of…

WATERTOWN, Mass., Oct. 18, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced it will host a corporate webcast to discuss topline results from the APOLLO Phase 3 trial of bitopertin in EPP. The webcast will be…

iShares MSCI Pacific ex Japan ETF (NYSEARCA:EPP - Get Free Report) was the recipient of a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 46,767 shares, an increase of 92.9% from the August 31st total of 24,243 shares. Approximately 0.1% of the company's shares

The yen's surge may be signaling something much bigger than another carry-trade scare: the price of Japanese capital is changing. For the first time in decades, rising JGB yields are making it increasingly rational for Japanese investors to keep more money at home.